Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Investigating conserved non-coding elements in cardiac development and congenital heart disease
FY 2023-24
Summary
Dr. Ian Scott, University of Toronto
Congenital heart disease (CHD) affects ~1% of live births and includes a range of structural and functional heart defects. Severe cases require multiple surgeries in the first years of life, and heart issues persist in adulthood. Currently, most CHD cases have no identifiable genetic cause, despite evidence that it is heritable. One missing piece of the diagnosis puzzle may be "non-coding" regions of the human genome, which are regions of DNA other than genes ("coding"). Some of these non-coding regions may include enhancers, which help determine the location and timing of gene expression. Enhancers can be considered analogous to dimmer-style light switches, fine-tuning the expression of a gene as opposed to a binary on/off switch. Mutations or errors in enhancer regions could cause incorrect regulation of genes and thus, improper development of essential structures such as the heart. Our lab has previously identified potential enhancer regions that may be critical for heart development as they are in proximity to heart-related genes. Accordingly, mutations in these enhancers that alter their ability to control gene expression may contribute to CHD. In partnership with the SickKids Cardiac Genome Clinic, non-coding mutations in CHD patients have been identified within our potential enhancers but have not been confirmed to be disease-causing. I am investigating these regions using a zebrafish animal model and comparing the ability of mutant vs. normal enhancers to regulate the expression of heart-related genes. I am also assessing whether these enhancer mutations cause errors in heart development. By functionally validating these potentially disease-causing variants, we can improve diagnostic testing for CHD and further our understanding of gene regulation in early heart development. Beyond CHD, this project addresses the overall challenge of understanding mutations in non-coding regions, which make up over 98% of our genome.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
495754
Name
Erkut Esra
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Investigating conserved non-coding elements in cardiac development and congenital heart disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cardiac Development; Congenital Heart Disease; Disease Modelling; Enhancers; Evolutionary Conservation; Gene Regulation; Non-Coding Mutations; Zebrafish
Abstract
Dr. Ian Scott, University of Toronto
Congenital heart disease (CHD) affects ~1% of live births and includes a range of structural and functional heart defects. Severe cases require multiple surgeries in the first years of life, and heart issues persist in adulthood. Currently, most CHD cases have no identifiable genetic cause, despite evidence that it is heritable. One missing piece of the diagnosis puzzle may be "non-coding" regions of the human genome, which are regions of DNA other than genes ("coding"). Some of these non-coding regions may include enhancers, which help determine the location and timing of gene expression. Enhancers can be considered analogous to dimmer-style light switches, fine-tuning the expression of a gene as opposed to a binary on/off switch. Mutations or errors in enhancer regions could cause incorrect regulation of genes and thus, improper development of essential structures such as the heart. Our lab has previously identified potential enhancer regions that may be critical for heart development as they are in proximity to heart-related genes. Accordingly, mutations in these enhancers that alter their ability to control gene expression may contribute to CHD. In partnership with the SickKids Cardiac Genome Clinic, non-coding mutations in CHD patients have been identified within our potential enhancers but have not been confirmed to be disease-causing. I am investigating these regions using a zebrafish animal model and comparing the ability of mutant vs. normal enhancers to regulate the expression of heart-related genes. I am also assessing whether these enhancer mutations cause errors in heart development. By functionally validating these potentially disease-causing variants, we can improve diagnostic testing for CHD and further our understanding of gene regulation in early heart development. Beyond CHD, this project addresses the overall challenge of understanding mutations in non-coding regions, which make up over 98% of our genome.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Erkut, Esra
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~